Prescription ID | TCMF912 |
Pinyin Name | Jian Nao An Shen Pian |
Chinese Name | 健脑安神片 |
English Name | Jian Nao An Shen Tablet |
Function Description | 头痛, 眩晕, 健忘, 不寐, 耳鸣 |
Indications | Tinnitus disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Headache, Dizziness, Insomnia |
Disease ICD-11 Category |
SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1)
]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; MB6Y [Other specified symptoms or signs involving the nervous system, 其他特指的累及神经系统的症状或体征 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; |
Human Tissues Associated with Indication | Heart, Brain |
Reference | Chinese pharmacopoeia (2015) |
Reference Book/link | ISBN 978-7-5067-7337-9 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1160 | Polygonatum sibiricum | 酒黄精 | TCMH1160 | ITSAH4762-14 |
TCMH1186 | Lycium chinense | 枸杞子 | TCMH1186 | ITSAO4545-14 |
TCMH1345 | Pulvis cornu cervi | 鹿角胶 | TCMH1345 | |
TCMH877 | Radix ginseng rubra | 红参 | TCMH877 | GBVE1679-11 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH746 | Carapax et plastrum testudinis | 龟甲 | TCMH746 | |
TCMH1549 | Kadsura longipedunculata | 南五味子 | TCMH1549 | GBVT370-13, GBVT825-13 |
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH2507 | Epimedium brevicornum | 淫羊藿 | TCMH2507 | AY362429 |
TCMH1362 | Herba sambuci chinensis | 陆英 | TCMH1362 | |
TCMH1346 | Cornu cervi degelatinatum | 鹿角霜 | TCMH1346 | |
TCMH388 | Ziziphus jujuba | 大枣 | TCMH388 | ITSAM869-14 |
TCMH1423 | Ophiopogon japonicus | 麦冬 | TCMH1423 | ITSAJ4140-14 |
TCMH2052 | Ziziphus jujuba var. spinosa | 酸枣仁 | TCMH2052 | ITSAM943-14 |
TCMH2554 | Polygala tenuifolia | 远志 | TCMH2554 | MF096619 |
TCMH206 | Fructus xanthii sibirici | 苍耳子 | TCMH206 | KJ496390 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT290 | CHRM5 | Muscarinic acetylcholine receptor M5 | GPCR | P08912 |
TCMT291 | CHRM3 | Muscarinic acetylcholine receptor M3 | GPCR | P20309 |
TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT34 | CYP2D6 | Cytochrome P450 2D6 | Oxidoreductase | P10635 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT632 | PNP | Purine nucleoside phosphorylase | Transferase | P00491 |
TCMT649 | DRD5 | Dopamine D5 receptor | GPCR | P21918 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT651 | DRD3 | Dopamine D3 receptor | GPCR | P35462 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT907 | FDPS | Farnesyl diphosphate synthase | Lyase | P14324 |
Target ID | Target Name |
---|---|
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1282 | Colletotrichum orbiculare |
TCMT1286 | Bacillus cereus |
TCMT1293 | Vaccinia virus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH | 9.74255 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 9.74255 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSD11B1, HSD17B1, HSPA1A, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, XDH | 9.74255 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 9.74255 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, HMGCR, IGF1R, INSR, MMP2, MMP9, PPARA, RORC, SRC, TEK | 9.58762 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, RORC, SMAD3, SRC, TEK | 9.57342 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FDPS, FUT7, HMGCR, HSD11B1, HSD17B1, MET, PPARA | 9.32855 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 8.92394 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FDPS, HMGCR, HSD11B1, HSD17B1 | 8.71993 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 8.58368 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 8.39885 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 8.28255 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH | 8.28255 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, RORC, SMAD3, SRC, TEK | 8.27969 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 8.00883 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FLT3, RORC, SRC, TEK | 7.92964 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, ESR1, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK | 7.65353 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK | 7.54696 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APP, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 7.48824 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 7.26216 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, APP, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 7.258 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 7.22055 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, APP, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 7.21045 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 7.15693 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK | 7.06439 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 7.02916 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CHRM5, CYP1A1, DRD3, FABP3, FDPS, FLT3, HCAR2, HMGCR, PPARA, RORC, SRC, TEK | 7.01823 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, APP, AXL, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH | 6.94255 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 6.94255 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH | 6.91928 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, CDC25B, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, TEK | 6.77415 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 6.7705 |
[BP] GO:0007200 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, ESR1 | 6.68191 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 6.67999 |
[BP] GO:0007197 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.61464 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 6.43239 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 6.41698 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, HMGCR, HSD11B1, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK | 6.41698 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, RORC, SMAD3, SRC | 6.41247 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 6.41138 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH | 6.40356 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 6.38037 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH | 6.33539 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC | 6.33539 |
[BP] GO:0007207 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.22656 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH | 6.19924 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 6.18139 |
[BP] GO:0003018 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, SRC, TEK | 6.14665 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK | 6.14346 |
[BP] GO:0007188 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 6.13553 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FDPS, FUT7, HMGCR, HSPA1A, PIM1, PPARA, XDH | 6.10125 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH | 6.06702 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH | 6.02594 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC | 6.02025 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH | 6.01519 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 6.00969 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK | 5.94309 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 5.87189 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK | 5.81202 |
[BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3 | 5.79724 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, HMGCR, KDR, SRC | 5.7184 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 | 5.70149 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, RORC, SMAD3, SRC | 5.67955 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR, FDPS, HMGCR | 5.67955 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 5.65096 |
[BP] GO:0007187 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 5.64808 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B1 | 5.61673 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, FABP3, FABP4, FDPS, FUT7, HMGCR, MET, PPARA | 5.60759 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.6062 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 5.58951 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 5.58951 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.56452 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK | 5.52699 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 5.43254 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 5.4266 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 5.42289 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HMGCR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK | 5.40013 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APP, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, RORC, SRC | 5.3815 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, RORC, SMAD3, SRC | 5.3815 |
[BP] GO:0030335 | positive regulation of cell migration | APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 5.37457 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK | 5.37457 |
[BP] GO:0050890 | None | ADORA1, APP, CHRM1, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR | 5.37457 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 5.35707 |
[BP] GO:0003013 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, SRC, TEK | 5.31441 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, PPARA, SRC, TEK | 5.29033 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK | 5.26084 |
[BP] GO:2000147 | positive regulation of cell motility | APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 5.23525 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, PPARA, SMAD3, TEK | 5.23525 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 5.22268 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 5.16297 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 5.11714 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 5.08449 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, HMGCR, KDR, SRC | 5.08449 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 5.06359 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR | 5.02195 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR | 5.02195 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK | 5.00616 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, APP, AXL, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HCAR2, HMGCR, HSPA1A, INSR, MMP9, PPARA, PTPN1, SMAD3, SRC | 4.98929 |
[BP] GO:0040017 | positive regulation of locomotion | APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 4.98537 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR, FDPS | 4.96033 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, APP, DRD2, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.89529 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK | 4.89035 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.84416 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, APP, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.79508 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, APP, AURKB, CDC25B, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.78975 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, HMGCR, KDR, SRC | 4.78975 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FDPS, HMGCR | 4.77969 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | DRD2, DRD3, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH | 4.75314 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA | 4.74401 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, XDH | 4.74339 |
[BP] GO:0008306 | None | APP, DRD1, DRD2, DRD3, DRD5, HMGCR | 4.70784 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.6969 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 | 4.69301 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AXL, CYP1B1, DRD1, DRD5, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RORC, SRC | 4.68941 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A | 4.67916 |
[BP] GO:0001963 | None | DRD1, DRD2, DRD3, DRD5 | 4.66045 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR | 4.65944 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1 | 4.60091 |
[BP] GO:0097746 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR | 4.5982 |
[BP] GO:0035296 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR | 4.5982 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK | 4.57407 |
[BP] GO:0007213 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.55992 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.55821 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, PPARA, SMAD3, SRC, TEK | 4.53796 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.52784 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH | 4.48784 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.48341 |
[BP] GO:0050801 | ion homeostasis | APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, SMAD3 | 4.48098 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK | 4.44802 |
[BP] GO:0045776 | None | ADORA1, DRD2, DRD3, DRD5, PPARA | 4.44802 |
[BP] GO:0050880 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR | 4.44594 |
[BP] GO:0035150 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR | 4.42625 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | APP, DRD2, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK | 4.42349 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AXL, CA2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HMGCR, HSPA1A, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK | 4.37677 |
[BP] GO:0007612 | None | APP, DRD1, DRD2, DRD3, DRD5, HMGCR, INSR | 4.37078 |
[BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, CYP19A1, DRD1, DRD2, DRD3, HMGCR, PPARA, SMAD3, TEK | 4.37004 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 4.37004 |
[BP] GO:0045787 | positive regulation of cell cycle | APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC | 4.33068 |
[BP] GO:0048511 | rhythmic process | AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, PPARA, RORC, SRC | 4.31574 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC | 4.28246 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HCAR2, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.26648 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, APP, AXL, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, INSR, SMAD3, SRC | 4.26644 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.24918 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 4.24109 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 4.22907 |
[BP] GO:0008542 | None | APP, DRD1, DRD2, DRD3, HMGCR | 4.20169 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, RORC, SRC | 4.17074 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK | 4.16666 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH | 4.13863 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.11333 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, APP, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HCAR2, INSR, SRC | 4.11333 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F3, INSR, MET, SRC, TEK | 4.09247 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, APP, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 4.07466 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP4, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH | 4.0688 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 4.05004 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 | 4.05004 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK | 4.01609 |
[BP] GO:0007632 | None | APP, DRD1, DRD2, DRD3, HMGCR | 4.01084 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.99513 |
[BP] GO:0095500 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.98792 |
[BP] GO:1903831 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.98792 |
[BP] GO:0051130 | positive regulation of cellular component organization | APP, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK | 3.97105 |
[BP] GO:0044057 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, DRD3, EGFR, GPR35, HCAR2, SMAD3 | 3.97074 |
[BP] GO:0007611 | None | APP, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR | 3.94238 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 | 3.91385 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, APP, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 3.79532 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK | 3.79532 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 | 3.79532 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 3.79532 |
[BP] GO:0001975 | None | DRD1, DRD2, DRD3, DRD5 | 3.7916 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA | 3.791 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC | 3.791 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC | 3.75414 |
[BP] GO:0007271 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.73128 |
[BP] GO:0051940 | None | DRD1, DRD2, DRD3 | 3.71131 |
[BP] GO:0051584 | None | DRD1, DRD2, DRD3 | 3.71131 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, INSR, SMAD3 | 3.71131 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, APP, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.6815 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APP, DRD1, DRD5, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC | 3.6715 |
[BP] GO:0090087 | None | ACHE, ADORA1, APP, CA2, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC | 3.6713 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.66997 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, DRD1, DRD2, DRD5 | 3.65942 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 3.64932 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3 | 3.64684 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, XDH | 3.6108 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.58539 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.51372 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK | 3.49245 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, APP, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.4878 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.48386 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, DRD2 | 3.46966 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, FDPS, HMGCR, HSD11B1, HSD17B1 | 3.46156 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | APP, DRD2, EGFR, HMGCR, KDR, SRC, TEK | 3.44718 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | CHRM5, FABP3, FLT3, SRC, TEK | 3.43846 |
[BP] GO:0007191 | None | DRD1, DRD3, DRD5 | 3.43366 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.43366 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH | 3.38438 |
[BP] GO:0050789 | regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.36983 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.34426 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, MMP2, MMP9 | 3.33856 |
[BP] GO:0007268 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 3.33856 |
[BP] GO:0098916 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 3.33856 |
[BP] GO:0021885 | forebrain cell migration | AXL, DRD1, DRD2, EGFR | 3.33648 |
[BP] GO:0009968 | negative regulation of signal transduction | DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH | 3.30507 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC | 3.30009 |
[BP] GO:0007267 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK | 3.28954 |
[BP] GO:0055080 | cation homeostasis | APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 | 3.27813 |
[BP] GO:0099536 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 3.27682 |
[BP] GO:0099537 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 3.27682 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 3.25697 |
[BP] GO:0007212 | None | DRD1, DRD2, DRD3, DRD5 | 3.25643 |
[BP] GO:0032467 | None | AURKB, CDC25B, DRD2, DRD3 | 3.25643 |
[BP] GO:0032872 | regulation of stress-activated MAPK cascade | APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH | 3.2392 |
[BP] GO:0070302 | regulation of stress-activated protein kinase signaling cascade | APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH | 3.22766 |
[BP] GO:0014075 | None | DRD1, DRD2, DRD3, DRD5 | 3.21578 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, MET, PPARA, PTPN1, RORC, SMAD3, SRC | 3.1901 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR | 3.18047 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, APP, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR, SRC, TEK | 3.16189 |
[BP] GO:0072507 | divalent inorganic cation homeostasis | APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 | 3.13235 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 3.11349 |
[BP] GO:0060134 | None | DRD1, DRD2, DRD3 | 3.11349 |
[BP] GO:0060158 | None | DRD1, DRD2, DRD5 | 3.11349 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 | 3.11212 |
[BP] GO:0008217 | None | ADORA1, DRD2, DRD3, DRD5, PPARA, SMAD3 | 3.10834 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 3.10754 |
[BP] GO:0010038 | response to metal ion | APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 | 3.10576 |
[BP] GO:0046960 | None | DRD1, DRD5 | 3.07704 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC | 3.06757 |
[BP] GO:0006584 | None | AKR1B1, DRD1, DRD2, DRD3 | 3.03047 |
[BP] GO:0009712 | None | AKR1B1, DRD1, DRD2, DRD3 | 3.03047 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 3.03047 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 3.03047 |
[BP] GO:0051580 | None | DRD1, DRD2, DRD3 | 3.03047 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK | 3.03047 |
[BP] GO:0097366 | None | DRD1, DRD2, DRD3, DRD5 | 2.95432 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC | 2.93147 |
[BP] GO:0030003 | cellular cation homeostasis | APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.92416 |
[BP] GO:0023052 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK | 2.90682 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 2.90224 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC | 2.90224 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 2.89529 |
[BP] GO:0042752 | None | ADORA1, DRD2, DRD3, PPARA, RORC | 2.87598 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.87159 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.86701 |
[BP] GO:0032225 | None | DRD1, DRD2, DRD3 | 2.86701 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK | 2.86118 |
[BP] GO:0006873 | cellular ion homeostasis | APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.85199 |
[BP] GO:0044267 | cellular protein metabolic process | ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK | 2.85197 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.83152 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.83152 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.83152 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.83152 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK | 2.82294 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ESR1, FABP4, FLT3, FUT7, HMGCR, KDR, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK | 2.82174 |
[BP] GO:0072593 | reactive oxygen species metabolic process | CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR | 2.81496 |
[BP] GO:0051726 | regulation of cell cycle | APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC | 2.80315 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 2.78838 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 2.78099 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, PIM1, PPARA, RORC, SRC | 2.77731 |
[BP] GO:0007154 | None | ADORA1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK | 2.77731 |
[BP] GO:0019226 | None | CHRM5, DRD1, DRD5 | 2.73875 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 2.73875 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK | 2.72376 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, INSR, MMP2, MMP9, SRC | 2.72048 |
[BP] GO:0043269 | regulation of ion transport | ADORA1, APP, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, GPR35, MMP9 | 2.71161 |
[BP] GO:0043086 | negative regulation of catalytic activity | APP, CSNK2A1, DRD2, DRD3, DRD5, DUSP3, FABP4, HMGCR, IGF1R, MMP9, PTPN1, SRC | 2.71158 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.7013 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.7013 |
[BP] GO:0019369 | arachidonic acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 2.7013 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.7013 |
[BP] GO:0046903 | None | ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, HSPA1A, MMP9, XDH | 2.68535 |
[BP] GO:0050877 | None | ADORA1, APP, CHRM1, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR | 2.68496 |
[BP] GO:0060160 | None | DRD2, DRD3 | 2.68496 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.68496 |
[BP] GO:0045187 | None | ADORA1, DRD2, DRD3 | 2.68496 |
[BP] GO:0007617 | None | APP, DRD1, DRD5 | 2.68496 |
[BP] GO:0010638 | positive regulation of organelle organization | AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 2.68496 |
[BP] GO:0032922 | None | DRD2, DRD3, PPARA, RORC | 2.6811 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR, HSD11B1, HSD17B1, XDH | 2.67813 |
[BP] GO:0090068 | positive regulation of cell cycle process | APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR | 2.67813 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, APP, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 2.67422 |
[BP] GO:0006874 | cellular calcium ion homeostasis | APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.64938 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, SRC | 2.64503 |
[BP] GO:0001503 | ossification | ALPL, EGFR, MMP2, MMP9, TEK | 2.63507 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2D6, RORC | 2.63507 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.63507 |
[BP] GO:0048148 | None | DRD1, DRD2, DRD3 | 2.63507 |
[BP] GO:0035813 | None | ADORA1, DRD2, DRD3 | 2.63507 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.63507 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.6343 |
[BP] GO:0051128 | regulation of cellular component organization | APP, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK | 2.62572 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, SMAD3, TEK | 2.62369 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC | 2.62369 |
[BP] GO:0002009 | morphogenesis of an epithelium | CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.6207 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC | 2.6207 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK | 2.61289 |
[BP] GO:0006464 | cellular protein modification process | ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK | 2.60622 |
[BP] GO:0036211 | protein modification process | ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK | 2.60622 |
[BP] GO:0009416 | response to light stimulus | APP, AURKB, DRD1, DRD2, DRD3, EGFR, HMGCR | 2.59748 |
[BP] GO:1903522 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, EGFR | 2.59748 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, DRD1, DRD2, EGFR | 2.59292 |
[BP] GO:0042749 | None | ADORA1, DRD2, DRD3 | 2.58819 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.58819 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, DRD1, DRD2, MET | 2.58537 |
[BP] GO:0055074 | calcium ion homeostasis | APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.58537 |
[BP] GO:0051223 | None | ACHE, APP, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC | 2.55921 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, MET, PPARA, RORC, SMAD3, SRC | 2.5543 |
[BP] GO:0072503 | cellular divalent inorganic cation homeostasis | APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.55243 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD17B1 | 2.54721 |
[BP] GO:0050878 | regulation of body fluid levels | ADORA1, AKR1B1, CHRM1, CHRM3, DRD2, F3, MET, XDH | 2.53939 |
[BP] GO:0080135 | regulation of cellular response to stress | APP, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, XDH | 2.53817 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.53817 |
[BP] GO:0040008 | regulation of growth | APP, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 | 2.51832 |
[BP] GO:0055082 | cellular chemical homeostasis | APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.51832 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA | 2.51465 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, SRC, TEK | 2.51465 |
[BP] GO:0044062 | None | ADORA1, DRD2, DRD3 | 2.48524 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.48524 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, SRC, TEK | 2.4846 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, MET, MMP9, PPARA, SRC | 2.47967 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, MMP9, SMAD3, SRC, XDH | 2.46906 |
[BP] GO:0022600 | None | CHRM1, CHRM3, CHRM5, DRD3 | 2.45412 |
[BP] GO:0006940 | None | ADORA1, CHRM1, CHRM2, CHRM3 | 2.45412 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.4541 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.4541 |
[BP] GO:0016125 | None | APP, CYP19A1, CYP1B1, FDPS, HMGCR | 2.44762 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, MMP2, MMP9 | 2.44762 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.44573 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1 | 2.44573 |
[BP] GO:0008299 | None | CYP1A1, FDPS, HMGCR | 2.44573 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.44573 |
[BP] GO:0007610 | None | APP, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR, PPARA | 2.43662 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, PPARA, RORC, SRC | 2.42313 |
[BP] GO:0015908 | None | DRD2, DRD3, FABP3, PPARA | 2.41857 |
[BP] GO:0055065 | metal ion homeostasis | APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 | 2.4102 |
[BP] GO:0050927 | None | F3, KDR, SMAD3 | 2.39867 |
[BP] GO:0032465 | None | AURKB, CDC25B, DRD2, DRD3 | 2.39754 |
[BP] GO:0070201 | None | ACHE, APP, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC | 2.39721 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, DRD2, EGFR, FLT3, INSR, PTPN1, SRC, TEK | 2.39721 |
[BP] GO:0048609 | multicellular organismal reproductive process | AKR1B1, APP, AXL, CYP1A1, DRD1, DRD5, EGFR, ESR1, SRC | 2.38616 |
[BP] GO:0050793 | regulation of developmental process | APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, HMGCR, INSR, KDR, NUAK1, PIM1, PPARA, RORC, SMAD3, SRC, TEK, XDH | 2.38357 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, PTPN1, SRC, TEK | 2.38114 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH | 2.38114 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, HMGCR | 2.37996 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HMGCR, HSD11B1, HSD17B1 | 2.37329 |
[BP] GO:0007416 | None | ACHE, APP, DRD1, DRD2 | 2.35991 |
[BP] GO:0050926 | None | F3, KDR, SMAD3 | 2.35991 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.35991 |
[BP] GO:0016477 | cell migration | AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP9, SRC, TEK | 2.3581 |
[BP] GO:0007623 | circadian rhythm | DRD2, DRD3, EGFR, PPARA, RORC | 2.34998 |
[BP] GO:0009653 | anatomical structure morphogenesis | APP, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK | 2.34927 |
[BP] GO:0007189 | None | DRD1, DRD2, DRD3, DRD5 | 2.31681 |
[BP] GO:0048731 | system development | ACHE, ADORA1, ALPL, CHRM1, CHRM2, CHRM3, MMP9, SMAD3, SRC, TEK | 2.30225 |
[BP] GO:0030534 | None | APP, DRD1, DRD2, DRD3, PPARA | 2.29655 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, DRD2, DRD3, GPR35, MMP9 | 2.28298 |
[BP] GO:0051172 | None | APP, AURKB, CSNK2A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP4, HMGCR, HSPA1A, IGF1R, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH | 2.27948 |
[BP] GO:0042417 | None | DRD1, DRD2, DRD3 | 2.27948 |
[BP] GO:0021853 | None | DRD1, DRD2 | 2.27948 |
[BP] GO:0046541 | None | CHRM1, CHRM3 | 2.27948 |
[BP] GO:0010641 | None | F3, SRC | 2.27948 |
[BP] GO:0090325 | None | DRD2, DRD3 | 2.27948 |
[BP] GO:1904936 | None | DRD1, DRD2 | 2.27948 |
[BP] GO:0042321 | None | ADORA1, DRD2 | 2.27948 |
[BP] GO:2000026 | regulation of multicellular organismal development | APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK, XDH | 2.26564 |
[BP] GO:0032413 | None | DRD2, DRD3, GPR35, MMP9 | 2.26447 |
[BP] GO:0050730 | None | ADORA1, APP, EGFR, FLT3, PTPN1, SRC | 2.25191 |
[BP] GO:0051952 | None | ADORA1, DRD1, DRD2, DRD3 | 2.24497 |
[BP] GO:0031100 | animal organ regeneration | AXL, CSNK2A1, EGFR, FLT3 | 2.24497 |
[BP] GO:0002791 | None | ACHE, ADORA1, DRD2, DRD3, EGFR, HCAR2, HMGCR, SRC | 2.24257 |
[BP] GO:0019098 | None | APP, DRD1, DRD5 | 2.24257 |
[BP] GO:0010564 | regulation of cell cycle process | APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR | 2.24257 |
[BP] GO:0040011 | locomotion | AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP9, SRC, TEK | 2.23784 |
[BP] GO:0051336 | regulation of hydrolase activity | APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, MMP9, NUAK1, PTPN1, SMAD3, SRC, XDH | 2.23784 |
[BP] GO:0009410 | None | DRD1, DRD2, DRD3, DRD5, EGFR | 2.23317 |
[BP] GO:1900542 | None | DRD1, DRD2, DRD3, DRD5, INSR, PPARA | 2.23148 |
[BP] GO:0042060 | None | DRD5, EGFR, PPARA, SMAD3 | 2.23148 |
[BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.22956 |
[BP] GO:0032880 | regulation of protein localization | ACHE, APP, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC | 2.2271 |
[BP] GO:0019932 | second-messenger-mediated signaling | DRD1, DRD2, DRD3, DRD5, EGFR, KDR | 2.22479 |
[BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, F3, MMP9, SMAD3, SRC, XDH | 2.21633 |
[BP] GO:0018958 | None | AKR1B1, DRD1, DRD2, DRD3 | 2.21533 |
[BP] GO:0071248 | cellular response to metal ion | CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.21389 |
[BP] GO:1901661 | None | AKR1B1, AKR1B10, HMGCR | 2.21223 |
[BP] GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | FLT3, SRC, TEK | 2.21223 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, EGFR | 2.21223 |
[BP] GO:0035303 | None | ADORA1, CHRM5, DRD2, NUAK1, SMAD3 | 2.20388 |
[BP] GO:0045936 | None | DRD2, DRD3, DUSP3, FABP4, HMGCR, IGF1R, PPARA, PTPN1, XDH | 2.19114 |
[BP] GO:0060341 | regulation of cellular localization | APP, CHRM1, CSNK2A1, DRD1, DRD2, DRD3, EGFR, HMGCR, PTPN1, SMAD3, SRC | 2.18747 |
[BP] GO:0010563 | None | DRD2, DRD3, DUSP3, FABP4, HMGCR, IGF1R, PPARA, PTPN1, XDH | 2.18747 |
[BP] GO:0006140 | None | DRD1, DRD2, DRD3, DRD5, INSR, PPARA | 2.17912 |
[BP] GO:0042220 | None | DRD2, DRD3, DRD5 | 2.17912 |
[BP] GO:1901890 | None | KDR, SMAD3, TEK | 2.17912 |
[BP] GO:0071276 | cellular response to cadmium ion | CYP1A2, EGFR, MMP9 | 2.17912 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2 | 2.17912 |
[BP] GO:0045744 | None | DRD2, DRD3, MET | 2.17912 |
[BP] GO:0051704 | multi-organism process | APP, AXL, CHRM2, CYP1A1, DRD3, EGFR, FDPS, HSPA1A, INSR, KDR, MET, MMP1, SMAD3, SRC | 2.17779 |
[BP] GO:0048167 | None | ADORA1, APP, DRD1, DRD2, DRD5 | 2.15057 |
[BP] GO:1901888 | regulation of cell junction assembly | KDR, SMAD3, SRC, TEK | 2.15057 |
[BP] GO:0071363 | cellular response to growth factor stimulus | APP, EGFR, INSR, KDR, SMAD3, SRC | 2.15057 |
[BP] GO:0022029 | None | DRD1, DRD2, EGFR | 2.15057 |
[BP] GO:0098801 | None | ADORA1, DRD2, DRD3 | 2.15057 |
[BP] GO:0021843 | None | DRD1, DRD2 | 2.15057 |
[BP] GO:1990535 | None | APP, INSR | 2.15057 |
[BP] GO:0021830 | None | DRD1, DRD2 | 2.15057 |
[BP] GO:0021826 | None | DRD1, DRD2 | 2.15057 |
[BP] GO:0046958 | None | DRD1, DRD5 | 2.15057 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP2D6 | 2.15057 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 2.14787 |
[BP] GO:0032410 | None | DRD2, DRD3, GPR35, MMP9 | 2.14135 |
[BP] GO:1904063 | None | DRD2, DRD3, GPR35, MMP9 | 2.14135 |
[BP] GO:0048729 | tissue morphogenesis | CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.13398 |
[BP] GO:0051781 | None | AURKB, CDC25B, DRD2, DRD3 | 2.12297 |
[BP] GO:0044419 | interspecies interaction between organisms | AXL, EGFR, FDPS, HSPA1A, INSR, KDR, MET, MMP1, SMAD3, SRC | 2.1228 |
[BP] GO:0090218 | positive regulation of lipid kinase activity | FLT3, SRC, TEK | 2.11994 |
[BP] GO:0010907 | None | INSR, PPARA, SRC | 2.11994 |
[BP] GO:0106027 | None | APP, IGF1R, INSR | 2.11994 |
[BP] GO:0051222 | positive regulation of protein transport | ACHE, APP, CHRM1, DRD2, EGFR, HCAR2, SMAD3, SRC | 2.10768 |
[BP] GO:0043412 | macromolecule modification | ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK | 2.10431 |
[BP] GO:0042058 | None | ADORA1, APP, EGFR, MMP9 | 2.09209 |
[BP] GO:0009894 | regulation of catabolic process | ADORA1, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 | 2.08935 |
[BP] GO:0006875 | cellular metal ion homeostasis | APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.08935 |
[BP] GO:0071868 | None | APP, DRD1, DRD5 | 2.08935 |
[BP] GO:0071870 | None | APP, DRD1, DRD5 | 2.08935 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK | 2.0856 |
[BP] GO:0002793 | None | ACHE, ADORA1, DRD2, EGFR, HCAR2, SRC | 2.0815 |
[BP] GO:0048870 | cell motility | AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP9, SRC, TEK | 2.0815 |
[BP] GO:0060359 | None | DRD1, DRD2, DRD3, DRD5 | 2.06201 |
[BP] GO:0090066 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR | 2.05067 |
[BP] GO:0051248 | None | APP, CSNK2A1, DUSP3, EGFR, FABP4, HMGCR, HSPA1A, IGF1R, MMP9, PTPN1, SMAD3, SRC, XDH | 2.04875 |
[BP] GO:2001023 | None | DRD1, DRD2, DRD3, MET | 2.04644 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AXL, CA2, CYP1B1, DRD2, F3, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK | 2.04028 |
[BP] GO:0051051 | negative regulation of transport | ADORA1, APP, DRD2, DRD3, GPR35, HMGCR, HSPA1A, MMP9 | 2.03831 |
[BP] GO:0009820 | alkaloid metabolic process | CYP1A2, CYP2D6 | 2.03831 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2D6 | 2.03831 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2D6 | 2.03831 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, SMAD3, XDH | 2.03596 |
[BP] GO:0045124 | None | CA2, EGFR, SRC | 2.03121 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, PPARA, RORC, SRC | 2.03073 |
[BP] GO:0009895 | negative regulation of catabolic process | ADORA1, EGFR, HCAR2, MET, PPARA, SMAD3 | 2.02639 |
[BP] GO:0046883 | regulation of hormone secretion | ADORA1, CYP19A1, DRD2, EGFR, HCAR2, HMGCR | 2.02639 |
[BP] GO:0019933 | None | DRD1, DRD2, DRD3, DRD5 | 2.02236 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, EGFR, FLT3, INSR, PTPN1, SRC | 2.01993 |
[BP] GO:0046328 | regulation of JNK cascade | APP, DUSP3, EGFR, IGF1R, PTPN1 | 2.01239 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | CYP1B1, EGFR, INSR, SMAD3, XDH | 2.01239 |
[BP] GO:0019725 | cellular homeostasis | APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 | 2.00592 |
[BP] GO:0007190 | None | ADORA3, DRD1, DRD5 | 2.00592 |
[BP] GO:0071867 | None | APP, DRD1, DRD5 | 2.00592 |
[BP] GO:0071869 | None | APP, DRD1, DRD5 | 2.00592 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK | 5.85139 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK | 5.70408 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, APP, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK | 4.86478 |
[CC] GO:0098590 | plasma membrane region | ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, EGFR, INSR, MET, SRC, TEK | 4.84728 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SRC, TEK | 4.73013 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK | 3.8602 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MET, PTPN1, SRC, TEK | 3.71131 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, CHRM3, EGFR, TEK | 3.58992 |
[CC] GO:0031253 | None | ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC | 3.13235 |
[CC] GO:0098793 | None | ADORA1, APP, CHRM1, CHRM2, CHRM3, DRD2 | 2.87598 |
[CC] GO:0045202 | None | ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR | 2.78838 |
[CC] GO:0043679 | None | CHRM1, CHRM2, CHRM3, DRD2 | 2.6811 |
[CC] GO:0044463 | None | ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, INSR, SRC | 2.64853 |
[CC] GO:0120038 | None | ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, INSR, SRC | 2.64853 |
[CC] GO:0044306 | None | CHRM1, CHRM2, CHRM3, DRD2 | 2.35991 |
[CC] GO:0031224 | None | ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MET, TEK | 2.31477 |
[CC] GO:0097730 | None | DRD1, DRD2, DRD5 | 2.15057 |
[CC] GO:0097443 | sorting endosome | KDR, PTPN1 | 2.15057 |
[CC] GO:0005783 | None | ADORA1, APP, CA4, CYP19A1, CYP2D6, FLT3, HMGCR, HSPA1A, KDR, PTPN1, XDH | 2.00594 |
[MF] GO:0043167 | ion binding | ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 10.0834 |
[MF] GO:0046914 | transition metal ion binding | ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH | 9.84488 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.84488 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK | 9.4373 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DUSP3, EGFR, F3, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, XDH | 9.19599 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 9.11599 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 8.15463 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK | 8.09478 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 7.92964 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.65353 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.94255 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK | 6.85655 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK | 6.85655 |
[MF] GO:0016907 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.61464 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.61287 |
[MF] GO:0030594 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 | 6.06334 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.8268 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.67955 |
[MF] GO:0043169 | cation binding | ACHE, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH | 5.62141 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 5.58951 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 5.35707 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 | 5.06134 |
[MF] GO:0004952 | None | DRD1, DRD2, DRD3, DRD5 | 5.01916 |
[MF] GO:0035240 | None | DRD1, DRD2, DRD3, DRD5 | 4.88496 |
[MF] GO:0070405 | ammonium ion binding | ACHE, CHRM3, DRD1, DRD2, DRD3, DRD5 | 4.65623 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 4.57882 |
[MF] GO:0015464 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.37185 |
[MF] GO:0042562 | hormone binding | ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR | 4.32554 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 4.32281 |
[MF] GO:1901338 | None | DRD1, DRD2, DRD3, DRD5 | 4.2096 |
[MF] GO:0005506 | iron ion binding | ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH | 3.96945 |
[MF] GO:0008227 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD2 | 3.87098 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.80695 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 3.61724 |
[MF] GO:0004629 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 3.57242 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.56544 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 3.49425 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.44882 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC | 3.43278 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR, HSD11B1, HSD17B1, XDH | 3.4274 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, XDH | 3.2999 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC | 3.27185 |
[MF] GO:0099528 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.21578 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC | 3.10754 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 3.07704 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 2.93043 |
[MF] GO:0019902 | phosphatase binding | EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 | 2.90144 |
[MF] GO:0046872 | metal ion binding | ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH | 2.86289 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, PPARA, RORC | 2.83337 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, PPARA, RORC | 2.83337 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.8012 |
[MF] GO:0004930 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GPR35, HCAR2 | 2.76884 |
[MF] GO:0042578 | None | ADORA1, ALPL, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 | 2.74109 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR, HSD17B1, SRC, XDH | 2.71958 |
[MF] GO:0016788 | None | ACHE, ADORA1, ALPL, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 | 2.67329 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, PPARA, RORC | 2.59292 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1 | 2.5696 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK | 2.55881 |
[MF] GO:0001588 | None | DRD1, DRD5 | 2.4541 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.4541 |
[MF] GO:0051425 | None | APP, INSR | 2.4541 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.42313 |
[MF] GO:0036094 | small molecule binding | ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH | 2.40752 |
[MF] GO:0004435 | None | CHRM1, CHRM3, CHRM5 | 2.31485 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.27948 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.27948 |
[MF] GO:0043548 | phosphatidylinositol 3-kinase binding | AXL, IGF1R, INSR | 2.24257 |
[MF] GO:0005102 | receptor binding | ADORA1, APP, DRD2, DRD3, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, PTPN1, SMAD3, SRC | 2.22479 |
[MF] GO:0005158 | None | IGF1R, PTPN1, SRC | 2.17912 |
[MF] GO:0004064 | arylesterase activity | CA1, CA2 | 2.15057 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 2.14787 |
[MF] GO:0043168 | anion binding | APP, AURKB, AXL, CSNK2A1, EGFR, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH | 2.12194 |
[MF] GO:0019899 | enzyme binding | APP, AURKB, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, F3, HMGCR, HSPA1A, MET, PPARA, PTPN1, SMAD3, SRC, TEK | 2.09926 |
[MF] GO:0005496 | steroid binding | ESR1, ESR2, HSD17B1, RORC | 2.09209 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2D6 | 2.08935 |
[MF] GO:0035258 | None | ESR1, FLT3, SMAD3, SRC | 2.06201 |
[MF] GO:0097159 | organic cyclic compound binding | ADORA1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FDPS, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 2.0541 |
[MF] GO:0042802 | identical protein binding | ACHE, APP, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, SMAD3, XDH | 2.03831 |
[MF] GO:0005021 | vascular endothelial growth factor-activated receptor activity | FLT3, KDR | 2.03831 |
[MF] GO:0030235 | nitric-oxide synthase regulator activity | EGFR, ESR1 | 2.03831 |
[MF] GO:0001609 | None | ADORA1, ADORA3 | 2.03831 |
[MF] GO:0008081 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 2.02236 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 11.1777 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, CYP1A1, CYP1B1, CYP19A1, IGF1R | 7.9801 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 8.1951 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, CHRM3, CHRM1, GPR35, ADORA3, CHRM5, ADORA1, DRD1, DRD2, DRD3, DRD5 | 7.3877 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, ESR1, EGFR, ESR2, HSPA1A | 6.1455 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD17B1, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 6.1455 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, EGFR, IGF1R | 5.3725 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, CHRM1, ADORA1, DRD1, DRD2, PPARA, DRD5 | 5.3874 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, INSR, KDR, TEK, DRD2, MET, EGFR, IGF1R | 5.2904 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.3971 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, CHRM3, CHRM1, CHRM5, DRD1, EGFR, DRD5 | 4.6517 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CHRM1, INSR, KDR, TEK, MET, EGFR, IGF1R | 3.8554 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP2D6, CYP1A2, CYP1A1, CYP1B1 | 4.3633 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.7201 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, FLT3, MMP1, MMP2, MMP9, MET, EGFR, IGF1R | 3.473 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM3, CHRM1, CHRM5 | 3.5698 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM3, CHRM1, SRC, CHRM5, EGFR | 3.2789 |
Ras signaling pathway_Homo sapiens_hsa04014 | INSR, KDR, TEK, MET, EGFR, IGF1R | 3.1858 |
Metabolic pathways_Homo sapiens_hsa01100 | FDPS, AKR1B1, HMGCR, CYP19A1, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, CYP1A2, CYP1A1, ALPL, XDH | 3.0664 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, MMP2, PIM1, F3 | 2.7533 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.2517 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIM1, CYP1B1, MMP9, MET, EGFR, CDC25B | 2.7066 |
Gap junction_Homo sapiens_hsa04540 | SRC, DRD1, DRD2, EGFR | 2.9469 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, MET, EGFR, IGF1R | 2.6194 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP1A2, CYP1A1, CYP1B1 | 3.0462 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | INSR, TEK, EGFR, IGF1R | 2.7378 |
Dopaminergic synapse_Homo sapiens_hsa04728 | DRD1, DRD2, DRD3, DRD5 | 2.4307 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, INSR, EGFR, IGF1R | 2.3954 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, INSR, ADORA1 | 2.4307 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | INSR, IGF1R, HSPA1A | 2.2957 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 2.7719 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET, EGFR | 2.2513 |
Melanoma_Homo sapiens_hsa05218 | MET, EGFR, IGF1R | 2.2042 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 2.1989 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 2.0129 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.2457 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 1.9543 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, INSR, PPARA | 1.766 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.5616 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, CYP2D6, ALOX5 | 1.7433 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.5139 |
AMPK signaling pathway_Homo sapiens_hsa04152 | INSR, HMGCR, IGF1R | 1.6405 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, SRC, MMP9 | 1.4839 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, INSR, ADORA1 | 1.3616 |
Prostate cancer_Homo sapiens_hsa05215 | EGFR, IGF1R | 1.1319 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC, EGFR | 1.1432 |
Glioma_Homo sapiens_hsa05214 | EGFR, IGF1R | 1.3352 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 1.0884 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.3616 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | INSR, IGF1R | 1.1085 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, DRD1 | 1.1277 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.3948 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.9682 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, HSPA1A | 0.8834 |
Gastric acid secretion_Homo sapiens_hsa04971 | CHRM3, CA2 | 1.2592 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 1.1298 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.9682 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, HSPA1A | 0.9682 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA, EGFR | 0.8945 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 0.9614 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.8784 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, INSR | 0.8784 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, EGFR | 1.3303 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 0.942 |
Pancreatic secretion_Homo sapiens_hsa04972 | CHRM3, CA2 | 1.0983 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.8784 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, IGF1R | 0.8784 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.2237 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.8784 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | INSR, EGFR | 0.8732 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3748 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | INSR, PPARA | 0.8582 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.3352 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, EGFR | 0.8362 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, HSPA1A | 0.694 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2D6, CYP1A2 | 1.3015 |
Bile secretion_Homo sapiens_hsa04976 | CA2, HMGCR | 1.2855 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.3352 |
Influenza A_Homo sapiens_hsa05164 | FDPS, HSPA1A | 0.7794 |
Alcoholism_Homo sapiens_hsa05034 | DRD1, DRD2 | 0.7678 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.3157 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.3516 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3418 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSPA1A | 0.3617 |
HTLV-I infection_Homo sapiens_hsa05166 | FDPS, SMAD3 | 0.5901 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.3512 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.3617 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.3414 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIM1 | 0.3777 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.3853 |
Cocaine addiction_Homo sapiens_hsa05030 | DRD1, DRD2 | 1.5029 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.4276 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.4512 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4431 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.4512 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4847 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3 | 0.5018 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | EGFR | 0.5092 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.5092 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC | 0.5134 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.5216 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1 | 0.5261 |
Taste transduction_Homo sapiens_hsa04742 | CHRM3 | 0.5436 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.5427 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.539 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.539 |
Salivary secretion_Homo sapiens_hsa04970 | CHRM3 | 0.539 |
Insulin secretion_Homo sapiens_hsa04911 | CHRM3 | 0.542 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.539 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5436 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3 | 0.5777 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.555 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.561 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5901 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.6012 |
Amphetamine addiction_Homo sapiens_hsa05031 | DRD1 | 0.5993 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.6052 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.6182 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.6031 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3 | 0.6135 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.8404 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | EGFR | 0.6413 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5 | 0.6135 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.6442 |
Endometrial cancer_Homo sapiens_hsa05213 | EGFR | 0.6623 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7959 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6817 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.7254 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | INSR | 0.6857 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6897 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.694 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | INSR | 0.752 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.0367 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7823 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.8604 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8277 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.8407 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8658 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | FDPS, HMGCR | 2.0637 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.8362 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8604 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 1.0474 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.1449 |